The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development
dc.contributor.author | Gagnier, Joel J. | en_US |
dc.contributor.author | Kienle, Gunver | en_US |
dc.contributor.author | Altman, Douglas G. | en_US |
dc.contributor.author | Moher, David | en_US |
dc.contributor.author | Sox, Harold | en_US |
dc.contributor.author | Riley, David | en_US |
dc.date.accessioned | 2013-12-04T18:58:14Z | |
dc.date.available | 2015-01-05T13:54:44Z | en_US |
dc.date.issued | 2013-11 | en_US |
dc.identifier.citation | Gagnier, Joel J.; Kienle, Gunver; Altman, Douglas G.; Moher, David; Sox, Harold; Riley, David (2013). "The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development." Headache: The Journal of Head and Face Pain (10): 1541-1547. | en_US |
dc.identifier.issn | 0017-8748 | en_US |
dc.identifier.issn | 1526-4610 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/101880 | |
dc.publisher | Oxford University Press | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Case Report | en_US |
dc.subject.other | Health Research Reporting Guideline | en_US |
dc.subject.other | Meaningful Use | en_US |
dc.subject.other | Patient Report | en_US |
dc.subject.other | EQUATOR Network | en_US |
dc.subject.other | Case Study | en_US |
dc.title | The CARE Guidelines: Consensus‐Based Clinical Case Reporting Guideline Development | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/101880/1/head12246.pdf | |
dc.identifier.doi | 10.1111/head.12246 | en_US |
dc.identifier.source | Headache: The Journal of Head and Face Pain | en_US |
dc.identifier.citedreference | Tully MP, Cantrill JA. Exploring the domains of appropriateness of drug therapy using the nominal group technique. Pharm World Sci. 2002; 24: 128 ‐ 131. | en_US |
dc.identifier.citedreference | Jenicek M. Clinical Case Reporting in Evidence‐Based Medicine, 2nd edn. New York: Oxford University Press; 2001. | en_US |
dc.identifier.citedreference | Riley D. Case reports in the era of clinical trials. Global Adv Health Med. 2013; 2: 10 ‐ 11. | en_US |
dc.identifier.citedreference | “Case reports” search results. http://www.ncbi.nlm.nih.gov/pubmed/?term=case+reports. Bethesda, MD; PubMed, US National Library of Medicine; 2013. Accessed June 10, 2013. | en_US |
dc.identifier.citedreference | Kaszkin‐Bettag M, Hildebrandt W. Case report on cancer therapies: The urgent need to improve the reporting quality. Global Adv Health Med. 2012; 1: 8 ‐ 10. doi: 10.7453/gahmj.2012.1.2.002. | en_US |
dc.identifier.citedreference | Kljakovic M. Single cases in general practice and general medical journals. Aust Fam Physician. 2002; 31: 669 ‐ 673. | en_US |
dc.identifier.citedreference | Richason TP, Paulson SM, Lowenstein SR, Heard KJ. Case reports describing treatments in the emergency medicine literature: Missing and misleading information. BMC Emerg Med. 2009; 9: 10. | en_US |
dc.identifier.citedreference | Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010; 152: 726 ‐ 732. | en_US |
dc.identifier.citedreference | von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, STROBE Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. BMJ. 2007; 335: 806 ‐ 808. | en_US |
dc.identifier.citedreference | Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA Statement. PLoS Med. 2009; 6: e1000097. doi: 10.1371/journal.pmed.1000097. | en_US |
dc.identifier.citedreference | Turner L, Shamseer L, Altman DG, Schulz KF, Moher D. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012; 1: 1 ‐ 60. doi: 10.1186/2046‐4053‐1‐60. | en_US |
dc.identifier.citedreference | Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Drug Saf. 2007; 30: 367 ‐ 373. | en_US |
dc.identifier.citedreference | Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010; 7: e1000217. doi: 10.1371/journal.pmed.100217. | en_US |
dc.identifier.citedreference | Williams PL, Webb C. The Delphi technique: A methodological discussion. J Adv Nurs. 1994; 19: 180 ‐ 186. | en_US |
dc.identifier.citedreference | Thomas B. Using nominal group technique to identify researchable problems. J Nurs Educ. 1983; 22: 335 ‐ 337. | en_US |
dc.identifier.citedreference | Horton JN. Nominal group technique: A method of decision‐making by committee. Anaesthesia. 1980; 35: 11 ‐ 14. | en_US |
dc.identifier.citedreference | Calvert M, Blazeby J, Altman DG, Revicki DA, Moher D, Brundage MD, CONSORT PRO Group. Reporting of patient‐reported outcomes in randomized trials: The CONSORT PRO extension. JAMA. 2013; 309: 814 ‐ 822. | en_US |
dc.identifier.citedreference | Vandenbroucke JP. In defense of case reports and case series. Ann Intern Med. 2001; 134: 330 ‐ 334. | en_US |
dc.identifier.citedreference | Journal of Medical Case Reports. http://www.jmedicalcasereports.com/. Accessed June 17, 2013. | en_US |
dc.identifier.citedreference | Cases Database. http://www.casesdatabase.com/. Accessed June 17, 2013. | en_US |
dc.identifier.citedreference | Hopewell S, Clarke M, Moher D, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: Explanation and elaboration. PLoS Med. 2008; 5: e20. doi: 10.1371/journal.pmed.0050020. | en_US |
dc.identifier.citedreference | Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors' implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: Interrupted time series analysis. BMJ. 2012; 344: e4178. doi: 10.1136/mj.e4178. | en_US |
dc.identifier.citedreference | Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS One. 2012; 7: e35621. doi: 10.1371/journal.pone.0035621. | en_US |
dc.identifier.citedreference | Hill AB. The environment and disease: Association or causation? Proc R Soc Med. 1965; 58: 295 ‐ 300. | en_US |
dc.identifier.citedreference | Kiene H, Hamre H, Kienle G. In support of clinical case reports: A system of causality assessment. Global Adv Health Med. 2013; 2: 76 ‐ 87. doi: 10.7453/gahmj.2012.061. | en_US |
dc.identifier.citedreference | Hauben M, Aronson JK. Gold standards in pharmaco‐vigilance: The use of definitive anecdotal reports of adverse drug reactions as pure gold and high‐grade ore. Drug Saf. 2007; 30: 645 ‐ 655. | en_US |
dc.identifier.citedreference | Vandenbroucke JP. Thalidomide: An unanticipated adverse effect. JLL Bulletin: Commentaries on the history of treatment evaluation. http://www.jameslindlibrary.org/illustrating/articles/thalidomide‐an‐unanticipated‐adverse‐effect. Accessed January 10, 2013. | en_US |
dc.identifier.citedreference | Levy M. Propranolol for infantile hemangiomas. Global Adv Health Med. 2012; 1: 14 ‐ 16. doi: 10.7453/gahmj.2012.1.2.004. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.